Embolic Stroke of Undetermined Source (ESUS) Criteria
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- ESUS Diagnosis Confirmed—
- ESUS Diagnosis Not Met—
- Inadequate Evaluation—
The Embolic Stroke of Undetermined Source (ESUS) Criteria calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include stroke type non lacunar. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Diagnostic criteria for identifying embolic stroke of undetermined source after comprehensive evaluation excluding other specific stroke etiologies.
Clinical Indication
The Embolic Stroke of Undetermined Source (ESUS) Criteria is indicated for bedside clinical practice to support Diagnostic criteria for identifying embolic stroke of undetermined source after comprehensive evaluation excluding other specific stroke etiologies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: Other specific causes to exclude: arteritis, dissection, migraine/vasospasm, drug misuse, genetic disorders, hypercoagulable states..
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: The diagnosis has implications for secondary stroke prevention strategies and treatment selection..
ESUS diagnosis requires ALL criteria to be met: (1) Non-lacunar stroke on imaging, (2) No significant atherosclerosis (≥50% stenosis), (3) No major cardioembolic source, (4) No other specific stroke cause, AND adequate diagnostic evaluation completed.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| stroke_type_non_lacunar | string | Yes | Non-lacunar stroke detected by CT or MRI (lacunar defined as subcortical infarct ≤1.5 cm or ≤2.0 cm on MRI diffusion images) |
| no_significant_atherosclerosis | string | Yes | Absence of extracranial or intracranial atherosclerosis causing ≥50% luminal stenosis in arteries supplying the area of ischemia |
| no_major_cardioembolic_source | string | Yes | No major cardioembolic sources identified (atrial fibrillation, intracardiac thrombus, prosthetic valve, cardiac tumors, mitral stenosis, recent MI <4 weeks, LVEF <30%, valvular vegetations, infective endocarditis) |
| no_other_specific_cause | string | Yes | No other specific cause of stroke identified (arteritis, dissection, migraine/vasospasm, drug misuse, genetic disorders) |
| adequate_cardiac_monitoring | string | Yes | Cardiac rhythm monitoring for ≥24 hours with automated rhythm detection completed |
| adequate_vascular_imaging | string | Yes | Adequate vascular imaging completed (catheter angiography, MR/CT angiography, or cervical duplex plus transcranial Doppler ultrasonography) |
| adequate_cardiac_imaging | string | Yes | Adequate cardiac imaging completed (transthoracic echocardiography and/or transesophageal echocardiography) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | ESUS Diagnosis Confirmed | Meets all ESUS criteria |
| — | ESUS Diagnosis Not Met | Does not meet ESUS criteria |
| — | Inadequate Evaluation | Insufficient diagnostic workup |
Evidence-Based References (EBM)
- Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429-38. doi: 10.1016/S1474-4422(13)70310-7.DOI: 10.1016/S1474-4422(13)70310-7
- Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
- Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K, et al. Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis. Stroke. 2015;46(8):2087-93. doi: 10.1161/STROKEAHA.115.009334.DOI: 10.1161/STROKEAHA.115.009334
- Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, et al. Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526-33. doi: 10.1177/1747493016641967.DOI: 10.1177/1747493016641967
- Diener HC, Bernstein R, Butcher K, Campbell B, Cloud G, Davalos A, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906-17. doi: 10.1056/NEJMoa1813959.DOI: 10.1056/NEJMoa1813959